Browsing: Biomarkers

Untitled design(2)
0

Read time: 4:30 mins
In this column, Afshin Safavi differentiates between ‘assay qualification’ and ‘assay validation’ explaining current industry guidance, the translation of this guidance into the exploratory biomarker world, and how Bioagilytix (NC, USA) approaches these challenges.

1 2 3 5